Antigen & Antibodies Market by Product (Antigens, ABs), Technique (ELISA, CLIA, IHS, IFA), Application (Diagnosis, Drug Discovery, Research), Healthcare Provider Facilities (ASCs & Clinics, Labs, Biotech& Pharma Companies) - Global Forecast to 2027
The global Antigen & Antibodies market size is projected to reach USD xx million by 2027 from USD xx million in 2022, at a CAGR of xx% during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
“The antibodies segment held the largest market share in 2021.”
Based on product, the Antigen and Antibodies Market is segmented into antigen and antibodies. The antibodies segment held the largest share in 2021, which is driven by its massive usage in the research and diagnosis in the area of infectious diseases, tumors and cancers, chronic and metabolic disorders.
“The ELISA segment accounted for the largest share in 2021
Based on the technique, the Antigen and Antibodies Market is segmented into ELISA, CLIA, IHS, IFA, Rapid Test and Others. The ELISA segment held the largest share owing to the massive application of ELISA technique using the antigen and antibodies for the diagnosis and research of various medical conditions and pathogens.
“Asia Pacific is estimated to register the highest CAGR during the study period. North America is expected to dominate the market share”
In this report, the Antigen and Antibodies Market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, Middle East & Africa and Latin America. North America to dominate the market in 2021, owing to adavnced infratsructure of healthcare and research, presence of leading players, and the massive prevalance of various chronic and infectious diseases.
Asia Pacific Market is expected to grow at the fastest CAGR during the forecast period of 2022 to 2027, this is attributed to the vast population base, expanding geriatrric popualtion and the increasing prevalance of infections, chronic diseases and cancer are creating more demand for research and diagnosis using antigen and antibodies.
Breakdown of primary supply-side interviews, by company type, designation, and region:
- By Company Type - Tier 1: 48%, Tier 2: 40%, and Tier 3: 12%
- By Designation - C-level: 44%, D-level: 30%, and Others: 26%
- By Region: North America (34%), Europe (26%), AsiaPacific (23%), and Rest of the World (17%)
To know about the assumptions considered for the study, download the pdf brochure
List of Companies Profiled in the Report
- Bio Rad Laboratories
- The Native Antigen Company
- Microbix Biosystems Inc.
- Creative Diagnostics
- Hytest
- Aalto Bio Reagents
- Advanced Biotechnologies Inc.
- ProSpec-Tany TechnoGene Ltd.
- ACROBiosystems Inc.
- GenWay Biotech Inc.
- Boster Biological Technology
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.9 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.4.3 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.6 PORTER FIVE FORCES ANALYSIS
5.8 COVID-19 IMPACT ANALYSIS
5.9 REGULATORY LANDSCAPE
5.10 TECHNOLOGY ANALYSIS
5.11 TRADE DATA ANALYSIS
5.12 PATENT ANALYSIS
6 ANTIGEN & ANTIBODIES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ANTIBODIES
6.2.1 INFECTIOUS DISEASE ANTIBODIES
6.2.2 TUMOR MARKER ANTIBODIES
6.2.3 CHRONIC AND METABOLIC DISORDER ANTIBODIES
6.2.4 OTHER ANTIBOIES
6.3 ANTIGEN
6.3.1 VIRAL ANTIGEN
6.3.2 BACTERIAL ANTIGEN
6.3.3 CARCINOGEN ANTIGEN
6.3.4 OTHER ANTIGENS
7 ANTIGEN & ANTIBODIES MARKET, BY TECHNIQUES
7.1 INTRODUCTION
7.2 ELISA
7.3 CLIA
7.2 IHS
7.3 IFA
7.2 RAPID TEST
7.3 OTHERS
8 ANTIGEN & ANTIBODIES MARKET, BY
8.1 INTRODUCTION
8.2 DISEASE DIAGNOSIS
8.3 DRUG DISCOVERY AND DEVELOPMENT
8.4 LIFE SCIENCE RESEARCH
8.5 OTHERS (IF ANY)
11 ANTIGEN & ANTIBODIES MARKET, BY HEALTHCARE PROVIDERS FACILITIES
11.1 HOSPITALS
11.2 AMBULATORY CARE CENTERS & CLINICS
11.3 CLINICAL LABORATORIES
11.4 HOME OR SELF TESTING
11.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11.6 RESEARCHERS AND ACADEMIA
12 ANTIGEN & ANTIBODIES MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 US
12.1.2 CANADA
12.2 EUROPE
12.2.1 GERMANY
12.2.2 UK
12.2.3 FRANCE
12.2.4 ITALY
12.2.5 SPAIN
12.2.6 REST OF ERUOPE
12.3 ASIA-PACIFIC
12.3.1 JAPAN
12.3.2 CHINA
12.3.3 INDIA
12.3.4 REST OF ASIA-PACIFIC
12.4 LATIN AMERICA
12.5 MIDDLE EAST AND AFRICA
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET SHARE/RANKING ANALYSIS, 2021 (IN TERMS OF % OF USD MILLION)
13.3 COMPETITIVE SCENARIO
13.3.1 PRODUCT LAUNCHES AND APPROVALS
13.3.2 PARTNERSHIPS, COLLABORATIONS, MERGERS, AND AGREEMENTS
13.3.3 EXPANSIONS
13.3.4 ACQUISITIONS
13.3.5 OTHER DEVELOPMENTS
13.4 COMPETITIVE LEADERSHIP MAPPING (2019)
13.4.1 STARS
13.4.2 EMERGING LEADERS
13.4.3 PERVASIVE
13.4.4 PARTICIPANTS
14 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 INTRODUCTION
14.2 BIO RAD LABORATORIES
14.3 THE NATIVE ANTIGEN COMPANY
14.4 MICROBIX BIOSYSTEMS INC.
14.5 CREATIVE DIAGNOSTICS
14.6 HYTEST
14.7 AALTO BIO REAGENTS
14.8 ADVANCED BIOTECHNOLOGIES INC.
14.9 PROSPEC-TANY TECHNOGENE LTD.
14.1 ACROBIOSYSTEMS INC.
14.11 GENWAY BIOTECH INC.
14.12 BOSTER BIOLOGICAL TECHNOLOGY
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
15.1 INSIGHTS OF INDUSTRY EXPERTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.4 AVAILABLE CUSTOMIZATIONS
15.5 RELATED REPORTS
15.6 AUTHOR DETAILS
Growth opportunities and latent adjacency in Antigen & Antibodies Market